D: Filing D
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 424B5: Prospectus
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | EFFECT: Others
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | EFFECT: Others
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer (related to financial reporting)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 20-F: Registration statement / Annual report / Transition report
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ariel Gordon.(6.9%)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alon Ben-Noon(19.98%)
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 424B3: Prospectus
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
NEUROSENSE THERAPEUTICS LTD C/WTS (TO PUR COM) | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data